GoAI
Get started
22nd Century Group, Inc. logo

22nd Century Group, Inc.

XXII

NASDAQConsumer DefensiveTobacco

Open in GoAI

Previous close

$3.756

−$0.1725 · -4.39%

Aug 21, 4:00 PM ET

XXII company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

26

Expensive

Momentum

21

Weakening

Sentiment

40

Bearish

Risk resilience

31

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

Industry
Tobacco
Sector
Consumer Defensive
Headquarters
US
CEO
Lawrence D. Firestone
Listed since
Jan 26, 2011
Employees
32

Market position

Day range

Current $3.756

52-week range

Current $3.756

Open
$4.09
Previous close
$3.9285
Volume
9.14K
0.29× average
Average volume
32.05K
Average daily volume
Market cap
1.3M USD
Beta
0.6
Market reference 1
50-day average
$4.4215
-15.05% below average
200-day average
$109.77
-96.58% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
39.58M USD
EV / EBITDA
-3.76×
Earnings yield
-11.89%
Free cash flow yield
-20.22%

Profitability & efficiency

Return on equity
-32.07%
Return on assets
-18.70%
Return on invested capital
-56.61%

Financial health

Current ratio
2.42×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends49%-128%-305%-481%Gross margin, FY2021: 4.80%Gross margin, FY2022: 4.56%Gross margin, FY2023: -27.00%Gross margin, FY2024: -20.21%Gross margin, FY2025: -44.50%Operating margin, FY2021: -91.81%Operating margin, FY2022: -83.05%Operating margin, FY2023: -139.52%Operating margin, FY2024: -117.44%Operating margin, FY2025: -161.95%Net margin, FY2021: -105.37%Net margin, FY2022: -147.65%Net margin, FY2023: -437.14%Net margin, FY2024: -127.66%Net margin, FY2025: -71.70%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 4.80%. Gross margin FY2022 4.56%. Gross margin FY2023 -27.00%. Gross margin FY2024 -20.21%. Gross margin FY2025 -44.50%. Operating margin FY2021 -91.81%. Operating margin FY2022 -83.05%. Operating margin FY2023 -139.52%. Operating margin FY2024 -117.44%. Operating margin FY2025 -161.95%. Net margin FY2021 -105.37%. Net margin FY2022 -147.65%. Net margin FY2023 -437.14%. Net margin FY2024 -127.66%. Net margin FY2025 -71.70%.

Income trends

Revenue

7.05M USD-40.65%

Operating income

−11.42M USD+18.16%

Net income

−5.05M USD+66.67%
Income trends across reported periods58.63M USD−13.88M USD−86.39M USD−158.9M USDRevenue, FY2021: 30.95M USDRevenue, FY2022: 40.5M USDRevenue, FY2023: 32.2M USDRevenue, FY2024: 11.88M USDRevenue, FY2025: 7.05M USDOperating income, FY2021: −28.41M USDOperating income, FY2022: −33.64M USDOperating income, FY2023: −44.93M USDOperating income, FY2024: −13.95M USDOperating income, FY2025: −11.42M USDNet income, FY2021: −32.61M USDNet income, FY2022: −59.8M USDNet income, FY2023: −140.78M USDNet income, FY2024: −15.16M USDNet income, FY2025: −5.05M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 30.95M USD. Revenue FY2022 40.5M USD. Revenue FY2023 32.2M USD. Revenue FY2024 11.88M USD. Revenue FY2025 7.05M USD. Operating income FY2021 −28.41M USD. Operating income FY2022 −33.64M USD. Operating income FY2023 −44.93M USD. Operating income FY2024 −13.95M USD. Operating income FY2025 −11.42M USD. Net income FY2021 −32.61M USD. Net income FY2022 −59.8M USD. Net income FY2023 −140.78M USD. Net income FY2024 −15.16M USD. Net income FY2025 −5.05M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue7.05M USD11.88M USD32.2M USD40.5M USD30.95M USD
Cost of goods sold10.19M USD14.28M USD40.9M USD38.65M USD29.46M USD
Gross profit−3.14M USD−2.4M USD−8.7M USD1.85M USD1.49M USD
Research and development688K USD1.13M USD2.64M USD3.58M USD3.91M USD
Selling, general, and administrative7.59M USD10.29M USD31.83M USD32.23M USD25.91M USD
Operating expenses8.28M USD11.55M USD36.24M USD35.48M USD29.9M USD
Interest income83K USD72K USD219K USD313K USD321K USD
Interest expense1.46M USD2.09M USD9.37M USD55K USD58K USD
Depreciation and amortization1.16M USD1.26M USD4.86M USD3.59M USD1.54M USD
Operating income−11.42M USD−13.95M USD−44.93M USD−33.64M USD−28.41M USD
Net income−5.05M USD−15.16M USD−140.78M USD−59.8M USD−32.61M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
-52.88
FY2025
Latest fiscal-year revenue
7.05M USD
FY2025 · -40.65% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend5,199,500.23-15,598,712.22-36,396,924.66-57,195,137.11FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend43.85M30.47M17.08M3.7MFY21FY22FY23FY24FY25

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$1,237.5

32847.28% upside
Past 12 months12-month forecastHigh $1,350Average $1,237.5Low $1,125

XXII news

globenewswire.com

22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026

MOCKSVILLE, N.C., Aug. 18, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harms of smoking driven…

Read source
seekingalpha.com

22nd Century Group, Inc. (XXII) Q2 2026 Earnings Call Prepared Remarks Transcript

22nd Century Group, Inc. (XXII) Q2 2026 Earnings Call Prepared Remarks Transcript

Read source
globenewswire.com

22nd Century Group Reports Second Quarter 2026 Financial Results

Advances VLN ® Commercialization Through Expanded Retail Support and Brand-Building Initiatives

Read source
globenewswire.com

22nd Century Group to Announce Second Quarter 2026 Results on August 13, 2026

MOCKSVILLE, N.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harms of smoking driven…

Read source
globenewswire.com

22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing

XXII investing in expanded marketing initiatives to drive VLN ® brand awareness and growth MOCKSVILLE, N.C., July 16, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused…

Read source

XXII peers

Walmart Inc. logo

WMT

Walmart Inc.

$103.7

-0.13%

Costco Wholesale Corporation logo

COST

Costco Wholesale Corporation

$947.74

+1.52%

PepsiCo, Inc. logo

PEP

PepsiCo, Inc.

$143.48

+0.99%

Monster Beverage Corporation logo

MNST

Monster Beverage Corporation

$47.79

+0.63%

Mondelez International, Inc. logo

MDLZ

Mondelez International, Inc.

$64.45

+0.48%

Coca-Cola Europacific Partners PLC logo

CCEP

Coca-Cola Europacific Partners PLC

$108

+1.08%

Continue in GoAI

Research XXII

research.disclaimer